12-2605076-C-T
Variant summary
Our verdict is Benign. Variant got -16 ACMG points: 0P and 16B. BP4_StrongBP6_Very_StrongBS2
The NM_000719.7(CACNA1C):c.2961-5C>T variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000192 in 1,612,258 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Consequence
NM_000719.7 splice_region, intron
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -16 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CACNA1C | NM_000719.7 | c.2961-5C>T | splice_region_variant, intron_variant | ENST00000399655.6 | NP_000710.5 | |||
CACNA1C | NM_001167623.2 | c.2961-5C>T | splice_region_variant, intron_variant | ENST00000399603.6 | NP_001161095.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CACNA1C | ENST00000399603.6 | c.2961-5C>T | splice_region_variant, intron_variant | 5 | NM_001167623.2 | ENSP00000382512.1 | ||||
CACNA1C | ENST00000399655.6 | c.2961-5C>T | splice_region_variant, intron_variant | 1 | NM_000719.7 | ENSP00000382563.1 | ||||
CACNA1C | ENST00000682544.1 | c.3111-5C>T | splice_region_variant, intron_variant | ENSP00000507184.1 | ||||||
CACNA1C | ENST00000406454.8 | c.2961-5C>T | splice_region_variant, intron_variant | 5 | ENSP00000385896.3 | |||||
CACNA1C | ENST00000399634.6 | c.2961-5C>T | splice_region_variant, intron_variant | 5 | ENSP00000382542.2 | |||||
CACNA1C | ENST00000683824.1 | c.3126-5C>T | splice_region_variant, intron_variant | ENSP00000507867.1 | ||||||
CACNA1C | ENST00000347598.9 | c.3021-5C>T | splice_region_variant, intron_variant | 1 | ENSP00000266376.6 | |||||
CACNA1C | ENST00000344100.7 | c.2961-5C>T | splice_region_variant, intron_variant | 1 | ENSP00000341092.3 | |||||
CACNA1C | ENST00000327702.12 | c.2961-5C>T | splice_region_variant, intron_variant | 1 | ENSP00000329877.7 | |||||
CACNA1C | ENST00000399617.6 | c.2961-5C>T | splice_region_variant, intron_variant | 5 | ENSP00000382526.1 | |||||
CACNA1C | ENST00000682462.1 | c.3051-5C>T | splice_region_variant, intron_variant | ENSP00000507105.1 | ||||||
CACNA1C | ENST00000683781.1 | c.3051-5C>T | splice_region_variant, intron_variant | ENSP00000507434.1 | ||||||
CACNA1C | ENST00000683840.1 | c.3051-5C>T | splice_region_variant, intron_variant | ENSP00000507612.1 | ||||||
CACNA1C | ENST00000683956.1 | c.3051-5C>T | splice_region_variant, intron_variant | ENSP00000506882.1 | ||||||
CACNA1C | ENST00000399638.5 | c.2961-5C>T | splice_region_variant, intron_variant | 1 | ENSP00000382547.1 | |||||
CACNA1C | ENST00000335762.10 | c.3036-5C>T | splice_region_variant, intron_variant | 5 | ENSP00000336982.5 | |||||
CACNA1C | ENST00000399606.5 | c.3021-5C>T | splice_region_variant, intron_variant | 1 | ENSP00000382515.1 | |||||
CACNA1C | ENST00000399621.5 | c.2961-5C>T | splice_region_variant, intron_variant | 1 | ENSP00000382530.1 | |||||
CACNA1C | ENST00000399637.5 | c.2961-5C>T | splice_region_variant, intron_variant | 1 | ENSP00000382546.1 | |||||
CACNA1C | ENST00000402845.7 | c.2961-5C>T | splice_region_variant, intron_variant | 1 | ENSP00000385724.3 | |||||
CACNA1C | ENST00000399629.5 | c.2961-5C>T | splice_region_variant, intron_variant | 1 | ENSP00000382537.1 | |||||
CACNA1C | ENST00000682336.1 | c.3036-5C>T | splice_region_variant, intron_variant | ENSP00000507898.1 | ||||||
CACNA1C | ENST00000399591.5 | c.2961-5C>T | splice_region_variant, intron_variant | 1 | ENSP00000382500.1 | |||||
CACNA1C | ENST00000399595.5 | c.2961-5C>T | splice_region_variant, intron_variant | 1 | ENSP00000382504.1 | |||||
CACNA1C | ENST00000399649.5 | c.2961-5C>T | splice_region_variant, intron_variant | 1 | ENSP00000382557.1 | |||||
CACNA1C | ENST00000399597.5 | c.2961-5C>T | splice_region_variant, intron_variant | 1 | ENSP00000382506.1 | |||||
CACNA1C | ENST00000399601.5 | c.2961-5C>T | splice_region_variant, intron_variant | 1 | ENSP00000382510.1 | |||||
CACNA1C | ENST00000399641.6 | c.2961-5C>T | splice_region_variant, intron_variant | 1 | ENSP00000382549.1 | |||||
CACNA1C | ENST00000399644.5 | c.2961-5C>T | splice_region_variant, intron_variant | 1 | ENSP00000382552.1 | |||||
CACNA1C | ENST00000682835.1 | c.2961-5C>T | splice_region_variant, intron_variant | ENSP00000507282.1 | ||||||
CACNA1C | ENST00000683482.1 | c.2952-5C>T | splice_region_variant, intron_variant | ENSP00000507169.1 | ||||||
CACNA1C | ENST00000682686.1 | c.2961-5C>T | splice_region_variant, intron_variant | ENSP00000507309.1 | ||||||
CACNA1C | ENST00000480911.6 | n.*1568-5C>T | splice_region_variant, intron_variant | 5 | ENSP00000437936.2 |
Frequencies
GnomAD3 genomes AF: 0.0000328 AC: 5AN: 152232Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000201 AC: 5AN: 249178Hom.: 0 AF XY: 0.0000222 AC XY: 3AN XY: 135192
GnomAD4 exome AF: 0.0000178 AC: 26AN: 1460026Hom.: 0 Cov.: 30 AF XY: 0.0000138 AC XY: 10AN XY: 726470
GnomAD4 genome AF: 0.0000328 AC: 5AN: 152232Hom.: 0 Cov.: 32 AF XY: 0.0000403 AC XY: 3AN XY: 74366
ClinVar
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | GeneDx | Dec 04, 2015 | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. - |
Long QT syndrome Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | May 27, 2023 | - - |
Cardiovascular phenotype Benign:1
Benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Apr 25, 2024 | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at